First Tracks Biotherapeutics, Inc.
First Tracks Biotherapeutics, Inc. scores highest on Nitro (73) and lowest on Price (9). Its PosiPenta is 46.72 out of 100, around the middle of similar companies.
On the Penta Grid this week, First Tracks Biotherapeutics, Inc. is Grid #347 of 836 in the Healthcare sector in United States, and Grid #2,252 of 3,999 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| First Tracks Biotherapeutics, Inc. | 46.72 | 9 | 27 | 73 | 66 | 58 |
| Absci Corporation | 47.10 | 12 | 43 | 74 | 58 | 48 |
| Azenta, Inc. | 56.39 | 39 | 56 | 77 | 68 | 42 |
| Intellia Therapeutics, Inc. | 37.94 | 27 | 30 | 41 | 48 | 45 |
| Generate Biomedicines, Inc. | 40.10 | 19 | 27 | 44 | 47 | 63 |
| Novavax, Inc. | 56.50 | 0 | 56 | 85 | 97 | 44 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -7.32 |
| P/B ratio | 7.29 |
EEarnings
| Trailing EPS | ₹-446.11 |
| Forward EPS | ₹-339.41 |
NNitro
| Price | 3263.88 |
| 52-week high | 4727.22 |
| 52-week low | 1394.20 |
| Fall from 52-week high | 31.0% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | 0.03 |
AAnchor
| Beta (price swings) | — |
| Market cap | ₹11,662 Cr |
| Insider holding | 8.75% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is First Tracks Biotherapeutics, Inc.'s PosiPenta score?
First Tracks Biotherapeutics, Inc.'s PosiPenta is 46.72 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does First Tracks Biotherapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, First Tracks Biotherapeutics, Inc. is Grid #347 of 836 in the Healthcare sector in United States, and Grid #2,252 of 3,999 in United States.
Which PosiPenta pillar is strongest for First Tracks Biotherapeutics, Inc.?
Nitro (momentum), with a score of 73 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for First Tracks Biotherapeutics, Inc.?
Price (valuation), with a score of 9 out of 100: much weaker than most similar companies.
Has First Tracks Biotherapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 1.82 points, from 44.90 to 46.72.
PositoAI is for research and education only and is not investment advice.